{"id":162239,"date":"2026-01-01T09:48:04","date_gmt":"2026-01-01T08:48:04","guid":{"rendered":"https:\/\/www.bcfi.be\/?post_type=avada_portfolio&#038;p=162239"},"modified":"2026-03-25T12:57:22","modified_gmt":"2026-03-25T11:57:22","slug":"vetmabs-pour-qui-pour-quoi-dans-quelles-conditions-quiz-medication","status":"publish","type":"avada_portfolio","link":"https:\/\/cbip.be\/fr\/portfolio\/vetmabs-pour-qui-pour-quoi-dans-quelles-conditions-quiz-medication\/","title":{"rendered":"Vetmabs : pour qui, pour quoi, dans quelles conditions ? \u2013 Quiz M\u00e9dication"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>Les anticorps monoclonaux v\u00e9t\u00e9rinaires (vetmabs) sont une classe de m\u00e9dicaments r\u00e9cemment arriv\u00e9s sur le march\u00e9.<\/p>\n<p>Pour quelles pathologies les utilise-t-on ? Y a-t-il des pr\u00e9cautions particuli\u00e8res \u00e0 prendre lorsqu\u2019on les administre ? Quels sont leurs effets ind\u00e9sirables ?<\/p>\n<p>A partir de quelques cas pratiques, dix questions vous seront pos\u00e9es et vous permettront de tester vos connaissances sur ces nouvelles substances.<\/p>\n<p>Ces situations pratiques sont g\u00e9n\u00e9ralement abord\u00e9es du point de vue du v\u00e9t\u00e9rinaire, qui, en pratique, administre ces m\u00e9dicaments. Cependant, elles permettront \u00e9galement aux pharmaciens de tester leurs connaissances sur les anticorps monoclonaux v\u00e9t\u00e9rinaires.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#9201; <b>XL &#8211; 1 heure<\/b><br \/>Testez vos connaissances sur ces nouvelles mol\u00e9cules en suivant notre nouveau Quiz M\u00e9dication !<br \/><b>Pharmacien d&rsquo;officine: 2 CP, V\u00e9t\u00e9rinaire: 1 PFCC (CRFOMV), V\u00e9t\u00e9rinaire: 2 PFCC (NGROD)<\/b><br \/>&#9202; derni\u00e8re mise \u00e0 jour mars 2026<\/p>\n","protected":false},"author":13,"featured_media":162241,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"footnotes":""},"portfolio_category":[172],"portfolio_skills":[145,14912,20306],"portfolio_tags":[36],"class_list":["post-162239","avada_portfolio","type-avada_portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-pour-les-veterinaires","portfolio_skills-pharmacien-dofficine-2-cp","portfolio_skills-veterinaire-1-pfcc-crfomv","portfolio_skills-veterinaire-2-pfcc-ngrod","portfolio_tags-quiz-medication"],"_links":{"self":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/162239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=162239"}],"version-history":[{"count":5,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/162239\/revisions"}],"predecessor-version":[{"id":180200,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/162239\/revisions\/180200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media\/162241"}],"wp:attachment":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=162239"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_category?post=162239"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_skills?post=162239"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_tags?post=162239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}